세계의 요오드 131 아이소토프 시장 : 용도, 최종 사용자, 형태, 치료 절차, 환자 인구 통계별 예측(2025-2030년)

The Iodine-131 Isotope Market was valued at USD 5.20 billion in 2023, expected to reach USD 5.52 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 8.07 billion by 2030.

Iodine-131 is a radioactive isotope extensively used in medical applications, particularly for diagnostic and therapeutic purposes in nuclear medicine. It is instrumental in the treatment of thyroid disorders, such as hyperthyroidism and certain types of thyroid cancer due to its ability to destroy tissue selectively. In the energy sector, Iodine-131 is also used as a tracer in hydraulic fracturing and diagnostics of countercurrent flow. The market for Iodine-131 is driven by the increasing prevalence of thyroid disorders globally, rising awareness and adoption of nuclear medicine, and advancements in radiopharmaceutical technology. A significant influencer of growth is the heightened investment in healthcare infrastructure and expanding geriatric population prone to thyroid conditions. Moreover, increasing demand for minimally invasive procedures contributes to the market's expansion. Recent opportunities include innovations in targeted radiopharmaceutical therapies, which can broaden the application of Iodine-131 in treating other cancer types, while improving delivery mechanisms can enhance its effectiveness and reduce side effects. However, challenges like stringent regulatory frameworks, high production costs, and the necessity for specialized handling and disposal procedures due to its radioactive nature can impede growth prospects. Limitations also arise from supply chain constraints and the need for consistent quality standards in production. To capitalize on market opportunities, developing strategic collaborations between research institutions and radiopharmaceutical companies is crucial. Areas ripe for innovation include research into novel carrier molecules for Iodine-131, improving precision in dose delivery, and expanding its application scope beyond thyroid-related conditions. The market is dynamic, characterized by rapid technological advancements and evolving therapeutic demands, which together underscore the importance of sustained research investment and regulatory compliance to maintain competitive advantage and market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Iodine-131 Isotope Market

The Iodine-131 Isotope Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
  • Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
  • Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
• Market Restraints
  • Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
• Market Opportunities
  • Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
  • Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
  • Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
• Market Challenges
  • Competition from alternative diagnostic and therapeutic isotopes

Porter's Five Forces: A Strategic Tool for Navigating the Iodine-131 Isotope Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Iodine-131 Isotope Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Iodine-131 Isotope Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Iodine-131 Isotope Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Iodine-131 Isotope Market

A detailed market share analysis in the Iodine-131 Isotope Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Iodine-131 Isotope Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Iodine-131 Isotope Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Iodine-131 Isotope Market

A strategic analysis of the Iodine-131 Isotope Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Iodine-131 Isotope Market, highlighting leading vendors and their innovative profiles. These include Advanced Accelerator Applications, Bayer AG, BRAHMS GmbH, Canon Medical Systems, Cardinal Health, Cardinal Health Nuclear & Precision Health Solutions, Curium, Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Isotopia Molecular Imaging, Mallinckrodt Pharmaceuticals, Medtronic, Nordion, NorthStar Medical Radioisotopes, NTP Radioisotopes, Philips Healthcare, Siemens Healthineers, Smiths Medical, and ZymoGenetics.

Market Segmentation & Coverage

This research report categorizes the Iodine-131 Isotope Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Application, market is studied across Agricultural, Industrial, Medical, and Pharmaceutical. The Agricultural is further studied across Pest Control and Soil Fertility Research. The Industrial is further studied across Diagnostics and Radiation Therapy. The Medical is further studied across Hyperthyroidism Treatment, Research and Development, and Thyroid Cancer Treatment. The Pharmaceutical is further studied across Radiopharmaceuticals.
• Based on End User, market is studied across Agricultural Sector, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes. The Hospitals and Clinics is further studied across Private Hospitals and Public Hospitals. The Research Institutes is further studied across Academic Research Institutes and Medical Research Institutes.
• Based on Form, market is studied across Capsules, Gas, and Liquid.
• Based on Therapeutic Procedures, market is studied across Radioactive Iodine Ablation, Radioactive Iodine Therapy, and Whole-Body Scan.
• Based on Patient Demographics, market is studied across Adults and Pediatrics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
    • 5.1.1.2. Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
    • 5.1.1.3. Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
  • 5.1.3. Opportunities
    • 5.1.3.1. Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
    • 5.1.3.2. Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
    • 5.1.3.3. Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Competition from alternative diagnostic and therapeutic isotopes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Iodine-131 Isotope Market, by Application

• 6.1. Introduction
• 6.2. Agricultural
  • 6.2.1. Pest Control
  • 6.2.2. Soil Fertility Research
• 6.3. Industrial
  • 6.3.1. Diagnostics
  • 6.3.2. Radiation Therapy
• 6.4. Medical
  • 6.4.1. Hyperthyroidism Treatment
  • 6.4.2. Research and Development
  • 6.4.3. Thyroid Cancer Treatment
• 6.5. Pharmaceutical
  • 6.5.1. Radiopharmaceuticals

7. Iodine-131 Isotope Market, by End User

• 7.1. Introduction
• 7.2. Agricultural Sector
• 7.3. Hospitals and Clinics
  • 7.3.1. Private Hospitals
  • 7.3.2. Public Hospitals
• 7.4. Pharmaceutical Companies
• 7.5. Research Institutes
  • 7.5.1. Academic Research Institutes
  • 7.5.2. Medical Research Institutes

8. Iodine-131 Isotope Market, by Form

• 8.1. Introduction
• 8.2. Capsules
• 8.3. Gas
• 8.4. Liquid

9. Iodine-131 Isotope Market, by Therapeutic Procedures

• 9.1. Introduction
• 9.2. Radioactive Iodine Ablation
• 9.3. Radioactive Iodine Therapy
• 9.4. Whole-Body Scan

10. Iodine-131 Isotope Market, by Patient Demographics

• 10.1. Introduction
• 10.2. Adults
• 10.3. Pediatrics

11. Americas Iodine-131 Isotope Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Iodine-131 Isotope Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Iodine-131 Isotope Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced Accelerator Applications
• 2. Bayer AG
• 3. BRAHMS GmbH
• 4. Canon Medical Systems
• 5. Cardinal Health
• 6. Cardinal Health Nuclear & Precision Health Solutions
• 7. Curium
• 8. Eckert & Ziegler
• 9. GE Healthcare
• 10. IBA Radiopharma Solutions
• 11. Isotopia Molecular Imaging
• 12. Mallinckrodt Pharmaceuticals
• 13. Medtronic
• 14. Nordion
• 15. NorthStar Medical Radioisotopes
• 16. NTP Radioisotopes
• 17. Philips Healthcare
• 18. Siemens Healthineers
• 19. Smiths Medical
• 20. ZymoGenetics